A new study will explore how psilocybin affects different networks and serotonin function in the brains of autistic adults.
Researchers explore the effect psychedelics have on the brain and how they are effective at treating depression.
Opioid use disorder is 30% less common in those who used psilocybin compared to those who have never been exposed to the psychedelic. Researchers say psilocybin may protect against opioid addiction by affecting the transmission of dopamine and serotonin.
AI technology helped map out diverse and subjective psychedelic experiences to different brain regions.
Researchers say they have found no evidence LSD microdosing improves mood or cognitive function.
The antidepressant effect of psilocybin-assisted therapy, in combination with psychotherapy, appears to provide up to a year of symptom relief for some patients with major depressive disorder.
A growing body of evidence suggests psychedelics including psilocybin and LSD show promise in providing lasting relief from symptoms for those suffering some mental health disorders. Researchers found DOI, a similar drug to LSD, reduced negative behavioral responses following fear triggers in mouse models of anxiety.
Drums, dance, sleep deprivation, and drugs, referred to as the 4D's in the rave scene was associated with personal transformation for those who considered a rave to be an awe-inspiring event. The more a person felt personally transformed by the experience, the more bonded to the fellow ravers they felt. This phenomenon may explain the long-standing popularity of the rave scene.